Author details

Full Name

Andrew P Morokoff

Affiliation

Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital

ORCID

Career Start Year

2001

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36302993	Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells.	Mol Cell Biochem	2023
37591452	Invadopodia associated Thrombospondin-1 contributes to a post-therapy pro-invasive response in glioblastoma cells.	Exp Cell Res	2023
37014551	Small extracellular vesicles promote invadopodia activity in glioblastoma cells in a therapy-dependent manner.	Cell Oncol (Dordr)	2023
36622685	Assessment of Safety of a Fully Implanted Endovascular Brain-Computer Interface for Severe Paralysis in 4 Patients: The Stentrode With Thought-Controlled Digital Switch (SWITCH) Study.	JAMA Neurol	2023
36834778	The Interleukin-11/IL-11 Receptor Promotes Glioblastoma Survival and Invasion under Glucose-Starved Conditions through Enhanced Glutaminolysis.	Int J Mol Sci	2023
36502448	The role of spinal surgery in the treatment of low back pain.	Med J Aust	2023
35266138	Machine learning approaches for imaging-based prognostication of the outcome of surgery for mesial temporal lobe epilepsy.	Epilepsia	2022
35269915	Extracellular Vesicles Secreted by Glioma Stem Cells Are Involved in Radiation Resistance and Glioma Progression.	Int J Mol Sci	2022
33123997	Lysophospholipid Signalling and the Tumour Microenvironment.	Adv Exp Med Biol	2021
33485596	Reversible cerebral vasoconstriction syndrome associated with hyperosmolar hyperglycaemic state: A case report and literature review.	J Clin Neurosci	2021
33801941	EGFRvIII Promotes Cell Survival during Endoplasmic Reticulum Stress through a Reticulocalbin 1-Dependent Mechanism.	Cancers (Basel)	2021
34892662	Non-Invasive Measurement of Intracranial Pressure Through Application of Venous Ophthalmodynamometry.	Annu Int Conf IEEE Eng Med Biol Soc	2021
34529228	Circulating tumor DNA for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.	J Neurooncol	2021
33442748	Circulating Biomarkers for Glioma: A Review.	Neurosurgery	2021
32390937	Endovascular Neuromodulation: Safety Profile and Future Directions.	Front Neurol	2020
33082482	Reduced EGFR and increased miR-221 is associated with increased resistance to temozolomide and radiotherapy in glioblastoma.	Sci Rep	2020
33026635	Correction to: Serum microRNA is a biomarker for post-operative monitoring in glioma.	J Neurooncol	2020
33050088	Inhibition of Radiation and Temozolomide-Induced Glioblastoma Invadopodia Activity Using Ion Channel Drugs.	Cancers (Basel)	2020
32915353	Serum microRNA is a biomarker for post-operative monitoring in glioma.	J Neurooncol	2020
30609109	Metabolic patterns and seizure outcomes following anterior temporal lobectomy.	Ann Neurol	2019
30048805	The epilepsy bioinformatics study for anti-epileptogenic therapy (EpiBioS4Rx) clinical biomarker: Study design and protocol.	Neurobiol Dis	2019
31451379	Solitary intraventricular Hodgkin lymphoma post-transplant lymphoproliferative disease (HL-PTLD): Case report.	J Clin Neurosci	2019
31281174	Learning Curve for Robot-Assisted Percutaneous Pedicle Screw Placement in Thoracolumbar Surgery.	Asian Spine J	2019
30822716	Glutamate weighted imaging contrast in gliomas with 7â¿¯Tesla magnetic resonance imaging.	Neuroimage Clin	2019
30907150	Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma.	Cancer Invest	2019
30562483	Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance.	Exp Cell Res	2019
29137915	First line direct access for transarterial embolization of a dural arteriovenous fistula: Case report and literature review.	J Clin Neurosci	2018
30219696	Inhibition of Radiation and Temozolomide-Induced Invadopodia Activity in Glioma Cells Using FDA-Approved Drugs.	Transl Oncol	2018
30250528	The role of interleukin-6-STAT3 signalling in glioblastoma.	Oncol Lett	2018
30478310	VDAC2 enables BAX to mediate apoptosis and limit tumor development.	Nat Commun	2018
29444091	A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.	PLoS One	2018
29148898	Enhancement of invadopodia activity in glioma cells by sublethal doses of irradiation and temozolomide.	J Neurosurg	2018
29172136	IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy.	Epilepsy Behav	2018
27771233	The emergent role of exosomes in glioma.	J Clin Neurosci	2017
28241049	Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.	PLoS One	2017
27896520	Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin.	J Neurooncol	2017
27098175	Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib.	Med Oncol	2016
27666131	Postoperative seizure control in patients with tumor-associated epilepsy.	Epilepsia	2016
27409404	Reoperation for Recurrent Glioblastoma and Its Association With Survival Benefit.	Neurosurgery	2016
27311724	Peritumoural glutamate correlates with post-operative seizures in supratentorial gliomas.	J Neurooncol	2016
26799295	Dynamics of circulating hypoxia-mediated miRNAs and tumor response in patients with high-grade glioma treated with bevacizumab.	J Neurosurg	2016
25439749	A novel treatment strategy for glioblastoma multiforme and glioma associated seizures: increasing glutamate uptake with PPARÎ³ agonists.	J Clin Neurosci	2015
26391593	MicroRNA as potential biomarkers in Glioblastoma.	J Neurooncol	2015
26308396	Preoperative biomarkers of tumour vascularity are elevated in patients with glioblastoma multiforme.	J Clin Neurosci	2015
26236828	Large suprasellar mass: question.	J Clin Neurosci	2015
26046374	The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cells.	Oncotarget	2015
25890775	Occult temporal lobe encephalocoele into the transverse sinus.	J Clin Neurosci	2015
25957782	Molecular subtypes, stem cells and heterogeneity: Implications for personalised therapy in glioma.	J Clin Neurosci	2015
25749043	Coexpression analysis of CD133 and CD44 identifies proneural and mesenchymal subtypes of glioblastoma multiforme.	Oncotarget	2015
24664947	Glutamate quantification in patients with supratentorial gliomas using chemical shift imaging.	NMR Biomed	2014

1 - 50 of 69

Farshad Nassiri

Toronto Western Hospital, University Health Network, University of Toronto

Career Start Year 2010

Number of shared co-authors 0

Jenny Kan-Suen Pu

Queen Mary Hospital

Career Start Year 2009

Number of shared co-authors 0

Rohan Ramakrishna

Weill Cornell Medical College, New York Presbyterian Hospital

Career Start Year 2009

Number of shared co-authors 0

Maryam Rahman

University of Florida

Career Start Year 2008

Number of shared co-authors 1

Yoshua Esquenazi

McGovern Medical School at UT Health Houston

Career Start Year 2007

Number of shared co-authors 0

Sherise D Ferguson

The University of Texas MD Anderson Cancer Center

Career Start Year 2005

Number of shared co-authors 0

Nancy Ann Oberheim Bush

University of California san francisco

Career Start Year 2005

Number of shared co-authors 0

Adam M Sonabend

Northwestern University

Career Start Year 2005

Number of shared co-authors 0

David J Pisapia

NewYork-Presbyterian Hospital - Weill Cornell Medicine

Career Start Year 2004

Number of shared co-authors 0

Gelareh Zadeh

University of Toronto

Career Start Year 2003

Number of shared co-authors 0

Matthias Preusser

Medical University of Vienna

Career Start Year 2003

Number of shared co-authors 0

Marco Skardelly

University Hospital Tubingen, Eberhard-Karls-University Tubingen

Career Start Year 2002

Number of shared co-authors 0

Ichiyo Shibahara

Kitasato University School of Medicine

Career Start Year 2002

Number of shared co-authors 0

Chul-Kee Park

College of Medicine, Seoul National University

Career Start Year 2000

Number of shared co-authors 0

Ghazaleh Tabatabai

University Hospital Tubingen, Eberhard-Karls-University Tubingen

Career Start Year 1998

Number of shared co-authors 0

John A Boockvar

Lenox Hill Hospital

Career Start Year 1997

Number of shared co-authors 1

Manish K Aghi

University of California san francisco

Career Start Year 1997

Number of shared co-authors 2

Vinay K Puduvalli

The University of Texas MD Anderson Cancer Center

Career Start Year 1996

Number of shared co-authors 1

Clark C Chen

University of Minnesota

Career Start Year 1994

Number of shared co-authors 0

Ganesh Rao

The University of Texas M.D. Anderson Cancer Center

Career Start Year 1994

Number of shared co-authors 0

Howard Colman

Huntsman Cancer Institute, University of Utah

Career Start Year 1990

Number of shared co-authors 1

Tom Mikkelsen

Ontario Brain Institute

Career Start Year 1990

Number of shared co-authors 1

Howard A Fine

Meyer Cancer Center

Career Start Year 1990

Number of shared co-authors 2

Bob S Carter

Massachusetts General Hospital and Harvard Medical School

Career Start Year 1990

Number of shared co-authors 0

Michael Weller

University Hospital and University of Zurich

Career Start Year 1987

Number of shared co-authors 1

Camilo E Fadul

University of Virginia Health System

Career Start Year 1987

Number of shared co-authors 0

Michael A Vogelbaum

Moffit Cancer Center

Career Start Year 1986

Number of shared co-authors 1

Ryo Nishikawa

Saitama Medical University International Medical Center

Career Start Year 1986

Number of shared co-authors 1

Frederick F Lang

The University of Texas M.D. Anderson Cancer Center

Career Start Year 1984

Number of shared co-authors 0

David Schiff

University of Virginia School of Medicine

Career Start Year 1966

Number of shared co-authors 2

row(s) 1 - 30 of 30

Terence J O'Brien

Monash University

Co-authored papers 17

Christopher M Hovens

Royal Melbourne Hospital, The University of Melbourne

Co-authored papers 4

Peter M Black

Brigham and Women's Hospital and Harvard Medical School

Co-authored papers 3

Vanessa Tsui

Co-authored papers 2

Terence P Speed

Co-authored papers 2

Jerome Engel

David Geffen School of Medicine at university of california los angeles

Co-authored papers 1

Courtney L Robertson

Johns Hopkins University

Co-authored papers 1

Jay Mocco

Icahn School of Medicine at Mount Sinai

Co-authored papers 1

Kristine O'Phelan

University of Miami

Co-authored papers 1

Richard J Staba

David Geffen School of Medicine at university of california los angeles

Co-authored papers 1

Meng Law

Co-authored papers 1

Manuel Buitrago Blanco

University of California Los Angeles

Co-authored papers 1

Jan Claassen

Columbia University

Co-authored papers 1

Emily J Gilmore

Yale University School of Medicine

Co-authored papers 1

David S Liebeskind

University of California Los Angeles (D.S.L.).

Co-authored papers 1

Ramon Diaz-Arrastia

University of Pennsylvania

Co-authored papers 1

Lara L Zimmermann

University of California davis

Co-authored papers 1

Natalie Kurganovs

Australian Prostate Cancer Research Centre Epworth

Co-authored papers 1

Frederick Willyerd

Phoenix Children's Hospital

Co-authored papers 1

Thomas P Bleck

Northwestern University Feinberg School of Medicine

Co-authored papers 1

Arthur W Toga

Keio University School of Medicine

Co-authored papers 1

Paul M Vespa

University of California los angeles

Co-authored papers 1

Alaa Kamnaksh

Uniformed Services University

Co-authored papers 1

Eric S Rosenthal

Beth Israel Deaconess Medical Center, Division of Neurocritical Care and Emergency Neurology, Division of Clinical Neurophysiology, Massachusetts General Hospital, Boston, MA, Harvard Medical School, Massachusetts General Hospital, Massachusetts General Hospital Fellowship in Epilepsy and Clinical Neurophysiology, Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School Fellowship Training Program in Neurocritical Care, Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School Partners Neurology Residency Training Program, Yale College

Co-authored papers 1

Michael J Bell

Children's National Hospital, George Washington University School of Medicine

Co-authored papers 1

Benjamin M Ellingson

David Geffen School of Medicine, University of California Los Angeles

Co-authored papers 1

David L McArthur

David Geffen School of Medicine, University of California Los Angeles

Co-authored papers 1

Brandon Foreman

University of Cincinnati